Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan vs Enalapril for AT1R-Ab in Lupus Nephritis
NCT03526042Unknown
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Sep 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of losartan in lupus nephritis (LN) and atherosclerosis (2 arms), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Primary endpoint: Carotid intima-media thickness change at 12 months. Status: unknown.
02
Drugs
losartan
03
Conditions
lupus nephritis (LN)atherosclerosis
Beyond the preview
Go deeper on NCT03526042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03526042.